Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
EV/EBITDA
42.56 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Alexion Pharmaceuticals Inc's enterprise value is $35,956 Mil. Alexion Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $845 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBITDA ratio for today is 42.56.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Alexion Pharmaceuticals Inc's stock price is $189.53. Alexion Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $2.40. Therefore, Alexion Pharmaceuticals Inc's P/E Ratio for today is 78.84.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Alexion Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=35956.135/844.832
=42.56

Alexion Pharmaceuticals Inc's current Enterprise Value is $35,956 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was 147.238 (Dec. 2013 ) + 222.242 (Mar. 2014 ) + 229.135 (Jun. 2014 ) + 246.217 (Sep. 2014 ) = $845 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Alexion Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=189.53/2.404
=78.84

Alexion Pharmaceuticals Inc's share price for today is $189.53.
Alexion Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -0.096 (Dec. 2013 ) + 0.79 (Mar. 2014 ) + 0.83 (Jun. 2014 ) + 0.88 (Sep. 2014 ) = $2.40.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda -3.28-8.54-9.94-33.9863.1743.3642.3751.2940.6044.36

Alexion Pharmaceuticals Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda 59.0854.7040.6035.8431.9741.0344.3643.7139.7637.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK